| Entry |
|
|---|
| Name |
TrenibotulinumtoxinE (JAN/USAN);
Botulin E |
|---|
| Formula |
C6452H9998N1702O1973S23
|
|---|
| Exact mass |
143626.7908
|
|---|
| Mol weight |
143714.16
|
|---|
| Sequence |
MPKINSFNYN DPVNDRTILY IKPGGCQEFY KSFNIMKNIW IIPERNVIGT TPQDFHPPTS
LKNGDSSYYD PNYLQSDEEK DRFLKIVTKI FNRINNNLSG GILLEELSKA NPYLGNDNTP
DNQFHIGDAS AVEIKFSNGS QHILLPNVII MGAEPDLFET NSSNISLRNN YMPSNHGFGS
IAIVTFSPEY SFRFNDNSIN EFIQDPALTL MHELIHSLHG LYGAKGITTT CIITQQQNPL
ITNRKGINIE EFLTFGGNDL NIITVAQYND IYTNLLNDYR KIASKLSKVQ VSNPQLNPYK
DIFQEKYGLD KDASGIYSVN INKFDDILKK LYSFTEFDLA TKFQVKCRET YIGQYKYFKL
SNLLNDSIYN ISEGYNINNL KVNFRGQNAN LNPRIIKPIT GRGLVKKIIR FCKNIVSVKG
IRKSICIEIN NGELFFVASE NSYNDDNINT PKEIDDTVTS NNNYENDLDQ VILNFNSESA
PGLSDEKLNL TIQNDAYIPK YDSNGTSDIE QHDVNELNVF FYLDAQKVPE GENNVNLTSS
IDTALLEQPK IYTFFSSEFI NNVNKPVQAA LFVSWIQQVL VDFTTEANQK STVDKIADIS
IVVPYIGLAL NIGNEAQKGN FKDALELLGA GILLEFEPEL LIPTILVFTI KSFLGSSDNK
NKVIKAINNA LKERDEKWKE VYSFIVSNWM TKINTQFNKR KEQMYQALQN QVNAIKTIIE
SKYNSYTLEE KNELTNKYDI KQIENELNQK VSIAMNNIDR FLTESSISYL MKLINEVKIN
KLREYDENVK TYLLNYIIQH GSILGESQQE LNSMVTDTLN NSIPFKLSSY TDDKILISYF
NKFFKRIKSS SVLNMRYKND KYVDTSGYDS NININGDVYK YPTNKNQFGI YNDKLSEVNI
SQNDYIIYDN KYKNFSISFW VRIPNYDNKI VNVNNEYTII NCMRDNNSGW KVSLNHNEII
WTLQDNAGIN QKLAFNYGNA NGISDYINKW IFVTITNDRL GDSKLYINGN LIDQKSILNL
GNIHVSDNIL FKIVNCSYTR YIGIRYFNIF DKELDETEIQ TLYSNEPNTN ILKDFWGNYL
LYDKEYYLLN VLKPNNFIDR RKDSTLSINN IRSTILLANR LYSGIKVKIQ RVNNSSTNDN
LVRKNDQVYI NFVASKTHLF PLYADTATTN KEKTIKISSS GNRFNQVVVM NSVGNNCTMN
FKNNNGNNIG LLGFKADTVV ASTWYYTHMR DHTNSNGCFW NFISEEHGWQ EK |
|---|
| Type |
Peptide |
|---|
| Class |
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
|
|---|
| Remark |
| Product (DG00772): | D00783<JP/US> D02735<US> D11405<US> D08957<US> D10012<JP/US> D10949<US> |
|
|---|
| Efficacy |
Skeletal muscle relaxant |
|---|
| Comment |
Treatment for the improvement in the appearance of glabellar lines
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS
M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
M03AX Other muscle relaxants, peripherally acting agents
M03AX01 Botulinum toxin
D13185 TrenibotulinumtoxinE (JAN/USAN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG00772 Botulinum toxin
D13185 TrenibotulinumtoxinE
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG00772 Botulinum toxin
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
